Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
It got into his eye too; two weeks later he had shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (Verbatim: It got into his eye too) (serious criteria GSK medically significant) and shingles (Verbatim: two weeks later he had shingles). The outcome of the ophthalmic herpes zoster and shingles were not reported. It was unknown if the reporter considered the ophthalmic herpes zoster and shingles to be related to Shingles vaccine. The company considered the ophthalmic herpes zoster and shingles to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 14-FEB-2025 This case was reported by the daughter/son of the patient via interactive digital media. Th reporter stated that his/her father (patient) went and got his Shingles vaccine and about two weeks later he had shingles. Reporter stated that it got into his eye too.; Sender's Comments: Ophthalmic herpes zoster and Herpes zoster are unlisted events which are considered unrelated to GSK Shingles vaccine.